简体中文 | 繁體中文 | English

Press Releases

2020-02-19 09:55 Bentley Systems Issues Call for Nominations for the Year in Infrastructure 2020 Awards Program
2020-02-19 09:52 Board International’s Rapid Growth Continues in 2019
2020-02-19 09:50 Boehringer-Ingelheim Launches Patient-Centric MyStudyWindow Powered by Carebox
2020-02-19 09:45 Western Union Launches Worldwide Coronavirus Relief Drive
2020-02-18 19:54 1.86 Customer Minutes Lost (CML) of Electricity per Year in Dubai
2020-02-18 19:42 Leman Micro Devices: Smartphones Can Detect Symptoms of Infection and Put Health Monitoring in Everyone’s Hands
2020-02-18 18:15 Mary Kay Inc. Announces Actress, Philanthropist Monique Coleman as First-Ever Pink Changing Lives Honoree
2020-02-18 17:58 “DEEP JAPAN” Exhibit on Seto Inland Sea Has Opened at Kansai International Airport
2020-02-18 13:53 B2Broker Introduces B2Core To Offer Businesses Brand New Pack-Based Trader’s Room Concept
2020-02-18 10:09 GSMA Board Statement on MWC Barcelona 2020
2020-02-17 18:28 NIPPON Platform and Global Loyalty Network (GLN) Led by Hana Bank Announce Strategic Business Partnership
2020-02-17 18:12 Mary Kay Participates in 2020 Generational Dermatology Palm Springs Symposium
2020-02-17 18:09 Octapharma Group Delivered Strong Growth in Both Sales and Operating Income In 2019
2020-02-17 18:03 Seoul Global Challenge 2019-2020 Finds Success in Finding Innovative Solutions to Reduce the Fine Dust in Seoul Subway
2020-02-17 17:00 Wider View, More Facts -- Hytera LTE Body Worn Camera VM780
2020-02-17 15:58 Plans to Develop AlUla, Saudi Arabia Into the ‘World’s Largest Living Museum’ by 2035 Unveiled at World Urban Forum 2020
2020-02-17 14:07 Artwork by David Oreilly – a Video Game Inspired by “Dazaifu”, Cultural Hub Connecting Japan with the Rest of East Asia – Currently Being Showcased at Fukuoka Airport from Sunday, February 9
2020-02-17 12:39 JEOL: Release of a New Ultrahigh Atomic Resolution Analytical Electron Microscope JEM-ARM300F2 (GRAND ARM(TM)2)
2020-02-17 11:51 NIPPON Passport Secures 200 Million JPY in Pre-Series A Funding
2020-02-17 10:06 Investigational Subcutaneous Formulation of Vedolizumab Achieves Clinical Remission at Week 52 in Patients with Moderately to Severely Active Crohn’s Disease

Business Wire Weibo

Industries

Latest Releases